Dawid Dorna
Poznan, WP, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The combinations of histone lysine demethylase inhibitors with panobinostat exert enhanced effects against head and neck cancer cells.
Journal: Experimental cell research
Published: February 16, 2026
Beyond the complex: inosine drives the antiviral and epigenetic effects of inosine pranobex.
Journal: Journal of applied genetics
Published: November 14, 2025
Honokiol Is More Potent than Magnolol in Reducing Head and Neck Cancer Cell Growth.
Journal: Current issues in molecular biology
Published: July 29, 2024
Triple Combinations of Histone Lysine Demethylase Inhibitors with PARP1 Inhibitor-Olaparib and Cisplatin Lead to Enhanced Cytotoxic Effects in Head and Neck Cancer Cells.
Journal: Biomedicines
Published: May 23, 2024
Natural products modulating epigenetic mechanisms by affecting histone methylation/demethylation: Targeting cancer cells.
Journal: British journal of pharmacology
Published: June 30, 2023
Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells.
Journal: International journal of molecular sciences
Published: May 23, 2023
Targeting cancer stem cells as a strategy for reducing chemotherapy resistance in head and neck cancers.
Journal: Journal of cancer research and clinical oncology
Published: May 04, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026